These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25828800)

  • 1. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.
    Rizzi A; Sukhtankar DD; Ding H; Hayashida K; Ruzza C; Guerrini R; Calò G; Ko MC
    Br J Pharmacol; 2015 Jul; 172(14):3661-70. PubMed ID: 25828800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt
    Cerlesi MC; Ding H; Bird MF; Kiguchi N; Ferrari F; Malfacini D; Rizzi A; Ruzza C; Lambert DG; Ko MC; Calo G; Guerrini R
    Eur J Pharmacol; 2017 Jan; 794():115-126. PubMed ID: 27871910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.
    Rizzi A; Malfacini D; Cerlesi MC; Ruzza C; Marzola E; Bird MF; Rowbotham DJ; Salvadori S; Guerrini R; Lambert DG; Calo G
    Br J Pharmacol; 2014 Sep; 171(17):4138-53. PubMed ID: 24903280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ.
    Guerrini R; Marzola E; Trapella C; Pela' M; Molinari S; Cerlesi MC; Malfacini D; Rizzi A; Salvadori S; Calo' G
    Bioorg Med Chem; 2014 Jul; 22(14):3703-12. PubMed ID: 24878361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
    Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
    Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
    Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
    Rizzi A; Gavioli EC; Marzola G; Spagnolo B; Zucchini S; Ciccocioppo R; Trapella C; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):968-74. PubMed ID: 17329551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
    Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
    Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
    Ding H; Hayashida K; Suto T; Sukhtankar DD; Kimura M; Mendenhall V; Ko MC
    Br J Pharmacol; 2015 Jul; 172(13):3302-12. PubMed ID: 25752320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
    D'Agostino B; Marrocco G; De Nardo M; Calò G; Guerrini R; Gallelli L; Advenier C; Rossi F
    Br J Pharmacol; 2005 Mar; 144(6):813-20. PubMed ID: 15685213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies.
    Ko MC; Wei H; Woods JH; Kennedy RT
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1257-64. PubMed ID: 16766718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.